Presentation is loading. Please wait.

Presentation is loading. Please wait.

None of the authors have any financial interests nor was the study supported by any unrestricted grant from government or non government agencies.

Similar presentations


Presentation on theme: "None of the authors have any financial interests nor was the study supported by any unrestricted grant from government or non government agencies."— Presentation transcript:

1 None of the authors have any financial interests nor was the study supported by any unrestricted grant from government or non government agencies.

2 Purpose – To objectively compare the efficacy of three pharmacological regimen post cataract extraction Design – IRB approved, prospective, randomized, single-blind study conducted at a single center, private, teaching practice in Las Vegas, Nevada. – Three variables (end points) were measured Degree of intraocular spike Degree anterior chamber inflammation Incidence of cystoid macular edema

3 Methods – Patients were randomized into three groups Control: gatifloxacin 0.3%, prednisolone acetate 1%, and bromfenac 0.09% (N = 41) Group I: gatifloxacin 0.3% and bromfenac 0.09% (N = 40) Group II: one intraoperative Triamcinolone acetonide injection, gatifloxacin 0.3% and bromfenac 0.09% (N = 30) – Pre-operative evaluation included a comprehensive dilated eye exam and base line OCT – Post-operative IOP and AC inflammation data were collected at 1-day, 1-week and 1-month for. OCTs were ordered at 1 week and 1 month – All surgeries were performed by one surgeon. All IOP measurements & OCT scans were performed by one certified tech

4 Results: Intraocular Pressure – Studied Population – Greatest IOP flux occurred on post-op day-1 Control & Group II – highest spike (7 & 6 mmHg) from baseline Group I: smallest spike (3 mmHg) and not statistically significant (p-value = 0.15) Results: IOP - Glaucoma Patients Statistical y significant between groups (p-value = 0.004) – All IOPs returned to baseline by week-1 Results: Anterior Chamber Inflammation Summed ocular inflammation score (SOIS) were used to assess degrees of inflammation Not statistically significant between groups: p-value = 0.39

5 Results – Macular OCT – Studied Population Foveal thickness between the groups showed no statistical significance (p = 0.82) – Macular OCT – Diabetic Population Foveal thickness within one-standard deviation of the mean between the three groups were not statistically significant (p = 0.35) – Macular OCT – Diabetic with NPDR Macular thickness was not statistically different (p = 0.45) Conclusion – Group I had the smallest IOP flux compared to Control & Group II – All three regimen were efficacious in controlling AC inflammation – All three regimen were efficacious in preventing cystoid macular edema in the non-diabetic and diabetic patients

6 Total/FinalEyeSexAge (years)POAG/ GS DMDM with NPDR Control49/41OD = 17 OS = 24 M = 20 F = 21 69.4 ± 11.31093 Group I48/40OD = 24 OS = 16 M = 15 F = 25 70.1 ± 12.48114 Group II40/30OD = 17 OS = 13 M = 12 F = 18 69.8 ± 11.6665 Key: M = male; F = female, POAG = primary open angle glaucoma; GS = glaucoma suspect; DM = diabetes mellitus II; NPDR = non-proliferative diabetic retinopathy

7 Intraocular pressure (mmHg)AC Inflammation (SOIS)OCT (µm) Pre1-day1-wk1-mthPre1-day1-wk 1- mth Pre1-wk1-mth Control15.4±3.222.2±8.115.4±3.215.0±3.702.1±0.40.80±0.40200±21204±20201±21 Group I15.3±2.718.2±5.514.9±2.514.2±2.502.2±0.40.79±0.40203±25205±23 Group II15.1±2.721.0±8.314.4±2.714.2±3.002.2±0.50.88±0.40199±25207±23201±24 p-value between groups = 0.150.390.82 p-value within groups = 0.120.430.06 Key: SOIS = summed ocular inflammatory score Table 2: Pre-operative & Post-operative Variable Data Effect – IOPValueF Hypothesis df Error dfSig. Partial Eta Squared Noncent. Parameter Observed Power b Pillai’s Trace Wilk’s Lambda Hotelling’s Trace Roy’s Largest Root 0.089 0.911 0.097 0.089 1.667 1680 a 1.692 3.185 c 6.000 3.000 214.000 212.000 210.000 107.000 0.130 0.127 0.124 0.027 0.045 0.046 0.082 10.003 10.079 10.152 9.555 0.629 0.633 0.636 0.722 a = Exact statistic; b = computed using alpha = 0.05; c = The statistic is an upper bound on F that yields a lower bound on the significance level; d = Design: intercept + group Table 3: Multivariate Tests – Power Analysis for Intraocular Pressure

8 Figure 1: Intraocular Pressure for the Studied Population

9 Figure 1: Intraocular Pressure for the Glaucoma Population

10 Diabetics (Total)Diabetic with NPDR Pre1-wk1-mthPre1-wk1-mth Control196±17 196±16204±17202±17199±6 Group I205±23211±21207±25206±23207±22202±29 Group II195±18203±17195±19199±19205±16203±18 p-value between groups = 0.350.77 p-value within groups = 0.450.85 Key: NPDR = non-proliferative diabetic retinopathy Table 5: OCT Data among Diabetics with and without NPDR EffectValueF Hypothesis df Error df Sig. Partial Eta Squared Noncent. Parameter Observed Power b Pillai’s Trace Wilk’s Lambda Hotelling’s Trace Roy’s Largest Root 0.080 0.920 0.087 0.086 2.243 2.269 a 2.295 4.654 c 4.000 2.000 216.000 214.000 212.000 108.000 0.065 0.063 0.060 0.012 0.040 0.041 0.042 0.079 8.972 9.078 9.180 9.307 0.651 0.657 0.662 0.773 a = Exact statistic; b = computed using alpha = 0.05; c = The statistic is an upper bound on F that yields a lower bound on the significance level; d = Design: intercept + group Table 4: Multivariate Tests – Power Analysis for Macular Edema

11 Efficacy among the three regimens in – Resolving anterior chamber inflammation – Preventing the development of macular edema – IOP spikes were significant in the glaucoma population on day-1 Group I – NSAIDs along demonstrated a lowest rise in IOP post-operatively Larger population size & longer post operative evaluation is warranted

12 References Moshirfar M, Feiz V, Vitale AT, et al. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology. 2007;114:686–691. Cho H, Wolf KJ, Wolf EJ. Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution. Clin Ophthalmol. 2009;3:199-210. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-516. Hirooka K, Shiraga F, Tanaka S, et al. Risk factors for elevated intraocular pressure after trans-tenon retrobulbar injections of triamcinolone. Jpn J Ophthalmol. 2006;50(3):235-238. Fang EN, Kass MA. Increased intraocular pressure after cataract surgery. Semin Ophthalmol. 1994;9:235-242. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007 May;114(5):881-889. Affiliations 1.Westfield Eye Center – 2575 Lindell Road, Las Vegas, NV 89146 2.Nevada State College – 1125 Nevada State Drive, Henderson, NV 89002 Contact Hon-Vu Q. Duong, M.D., 2575 Lindell Road, Las Vegas, NV 89146 Email: hon-vu.duong@nsc.nevada.edu


Download ppt "None of the authors have any financial interests nor was the study supported by any unrestricted grant from government or non government agencies."

Similar presentations


Ads by Google